Lynk Pharmaceuticals and Formation Bio Enter Exclusive Development and Licensing Agreement for LNK01006
HANGZHOU, China and SHANGHAI and BOSTON, Dec. 10, 2025 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as "Lynk Pharmaceuticals") and Formation Bio today announced Formation Bio's acquisition of worldwide rights, excluding...
Exploring the Next Era of CGT and Unlocking Limitless Possibilities: The GenScript Biotech Global Forum London 2025 Wraps Up
PISCATAWAY, N.J., Nov. 22, 2025 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, successfully hosted the GenScript Biotech Global Forum London 2025 in the UK. This marks the Forum's...
Clarity Eye Centre Brings SILK™ Laser Eye Technology to Hong Kong
HONG KONG, Nov. 20, 2025 /PRNewswire/ -- Clarity Eye Centre announced the arrival of Johnson & Johnson's next-generation SILK™ Laser Eye Technology, now available to patients in Hong Kong. The clinic is the first in the city to widely offer the...
SNEF Marks 45 Years as the Voice of Employers in Singapore's Tripartite System
SINGAPORE, Nov. 4, 2025 /PRNewswire/ -- The Singapore National Employers Federation (SNEF) commemorated 45 years as the voice of employers in Singapore's tripartite system at the SNEF45 Employers' Summit on 4 November 2025. Themed Forging the Future...
Johnson & Johnson Showcases Latest Advancements in Pulsed Field Ablation with Multiple Clinical and Real-world Studies at APHRS and JPHRS
Key oral presentations highlight new safety, efficacy and workflow improvements data to optimize irrigation and support consistent procedural outcomes. YOKOHAMA, Japan, Nov. 3, 2025 /PRNewswire/ -- Johnson & Johnson MedTech, a global leader in...
Exploring the Next Era of Cell & Gene Therapy with Nobel Laureate in London
PISCATAWAY, N.J., Oct. 20, 2025 /PRNewswire/ -- London will become the global spotlight for cell and gene therapy (CGT) this November as Nobel Laureate, scientific leaders, biotech innovators, and top investors convene to chart the future of one of...
CGBIO Receives FDA IDE Approval for NOVOSIS PUTTY, Advancing Toward U.S. Market Entry
- The bone graft incorporating rhBMP-2 has received FDA IDE approval for a pivotal clinical trial in spinal fusion - Positioned for global expansion in $750M spinal bone graft market SEOUL, South Korea, April 24, 2025 /PRNewswire/ -- CGBIO(CEO Hyun...
Terumo Blood and Cell Technologies Names Patrick Daly as Chief Business Officer
Daly, a 30-year veteran of the healthcare industry, is the latest leadership addition to help Terumo BCT unite business areas and fuel enterprise growth LAKEWOOD, Colo., April 17, 2025 /PRNewswire/ -- Terumo Blood and Cell Technologies (Terumo BCT),...
VISTA Eye Specialist Enhances Cataract Surgery with Advanced Technology and Strategic Partnerships
PETALING JAYA, Malaysia, March 14, 2025 /PRNewswire/ -- Klinik Pakar Mata VISTA Eye Specialist (VISTA), a well-established name in eye care in Malaysia, continues to improve its cataract surgery services through collaborations with recognized...
See the Future with Luck: VISTA Eye Specialist Promotes Eye Health with CNY Eye Carnival Nationwide
PETALING JAYA, Malaysia, Feb. 14, 2025 /PRNewswire/ -- As people live longer, ensuring a purposeful and fulfilling life becomes even more important. Life expectancy in Malaysia has steadily increased to 76.26 years ([1]), highlighting the growing...